Versant Vantage I, L.p.

Affiliations

  • at Monte Rosa Therapeutics Inc. (GLUE), 2024-10-30
  • at Black Diamond Therapeutics Inc. (BDTX), 2024-08-30
  • Large Shareholder at Contineum Therapeutics Inc. (CTNM), 2024-04-11
  • Large Shareholder at Rayzebio Inc. (RYZB), 2023-09-15
  • Large Shareholder at Oyster Point Pharma Inc. (OYST), 2023-01-04
  • Large Shareholder at Repare Therapeutics Inc. (RPTX), 2022-06-07
  • Large Shareholder at Aligos Therapeutics Inc. (ALGS), 2020-10-20
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-21
  • Large Shareholder at Aprea Therapeutics Inc. (APRE), 2020-05-21
  • Large Shareholder at Passage Bio Inc. (PASG), 2020-03-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RPTX $20.00 100,000 Large Shareholder 3,419,451 2020-06-23 Filing
RPTX $20.00 150,000 Large Shareholder 608,282 2020-06-23 Filing
APRE $15.00 333,333 333,333 2019-10-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RPTX $12.25 33,395 Large Shareholder 111,484 2022-06-03 Filing
RPTX $12.25 14,611 Large Shareholder 48,776 2022-06-03 Filing
RPTX $12.25 13,199 Large Shareholder 44,065 2022-06-03 Filing
RPTX $12.25 438,795 Large Shareholder 1,464,875 2022-06-03 Filing
RPTX $12.25 250,000 Large Shareholder 2,344,451 2022-06-03 Filing